Physician profile
Matthew Stringer
NPI 1437470804
$7,152.53
in general payments reported to CMS, 2019-2025
23 companies · $1,823 in 2025
The $1,823 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $28.51 · 2021: $205 · 2022: $3,144 · 2023: $1,021 · 2024: $563 · 2025: $1,823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,277 · Education: $99.99 · Travel and Lodging: $30.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,277.36 |
| Education | $99.99 |
| Travel and Lodging | $30.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $3,163.99 | 2021-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $1,989.74 | 2022-2025 | Rezum Generator |
| Janssen Biotech, INC. | $248.78 | 2025 | Erleada |
| Coloplast Corp | $200.19 | 2021-2025 | Altis |
| Axonics, INC. | $150.47 | 2022-2024 | Axonics |
| Neotract INC. | $150.00 | 2019 | |
| Astellas Pharma US INC | $149.52 | 2024-2025 | Xtandi |
| Olympus America INC. | $133.94 | 2021-2025 | Itind System, Uretero-Reno Fiberscope |
| Sumitomo Pharma America, INC. | $129.65 | 2025 | Gemtesa |
| Pfizer INC. | $121.73 | 2019 | |
| Antares Pharma, INC. | $104.77 | 2025 | Xyosted |
| Abbvie INC. | $100.37 | 2025 | |
| Endo USA, INC. | $92.72 | 2024-2025 | Aveed, Xiaflex |
| Endo Pharmaceuticals INC. | $89.37 | 2020-2023 | Aveed, Xiaflex |
| Bard Access Systems, INC. | $65.43 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $48.26 | 2023-2024 | Jelmyto |
| Tolmar, INC. | $42.20 | 2025 | Eligard, Jatenzo |
| Blue Earth Diagnostics | $33.97 | 2025 | Posluma |
| Laborie Medical Technologies Corp. | $32.95 | 2025 | |
| Cook Medical LLC | $30.59 | 2019 | |
| 180 Medical, INC. | $26.61 | 2025 | |
| Procept Biorobotics Corporation | $24.52 | 2025 | |
| Bioprotect Medical, INC. | $22.76 | 2025 | Bioprotect Balloon Implant System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Stringer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.